(Reuters) – British drugmaker Indivior on Thursday said it appointed Joe Ciaffoni as its new CEO, replacing current boss Mark Crossley. Crossley, who joined the company in 2012, will be stepping down after a near five-year tenure as the company’s CEO, Indivior said. Ciaffoni, an independent non-executive director at the firm since December 2024, will […]
Health
UK’s Indivior appoints Joe Ciaffoni as CEO
Audio By Carbonatix
(Reuters) – British drugmaker Indivior on Thursday said it appointed Joe Ciaffoni as its new CEO, replacing current boss Mark Crossley.
Crossley, who joined the company in 2012, will be stepping down after a near five-year tenure as the company’s CEO, Indivior said.
Ciaffoni, an independent non-executive director at the firm since December 2024, will assume the leadership role pending shareholder approval of a new remuneration policy at the annual general meeting in May, the company said in a statement.
Last week, the drugmaker projected a 17% fall in 2025 net revenue, partly due to weak sales of its film-form medication-assisted therapy.
(Reporting by Raechel Thankam Job; Editing by Mrigank Dhaniwala and Varun H K)